BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
122.000 |
Evidence |
O
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
121.000 |
Evidence |
|
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
117.000 |
Evidence |
|
NRAS |
NRAS, HRAS1: GTPase NRas precursor |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
114.000 |
Evidence |
O
|
ERCC5 |
ERCC5, ERCM2, XPG, XPGC: DNA-repair protein complementing XP-G cells |
GTF2H1 |
GTF2H1, BTF2: TFIIH basal transcription factor complex p62 subunit |
100.000 |
Evidence |
O
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
LYN |
LYN: Tyrosine-protein kinase Lyn |
78.230 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
51.550 |
Evidence |
O
|
ERCC2 |
ERCC2, XPD, XPDC: TFIIH basal transcription factor complex helicase subunit |
GTF2H1 |
GTF2H1, BTF2: TFIIH basal transcription factor complex p62 subunit |
48.780 |
Evidence |
O
|
ERCC2 |
ERCC2, XPD, XPDC: TFIIH basal transcription factor complex helicase subunit |
ERCC5 |
ERCC5, ERCM2, XPG, XPGC: DNA-repair protein complementing XP-G cells |
40.320 |
Evidence |
O
|
TP53 |
TP53, P53: Cellular tumor antigen p53 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
36.060 |
Evidence |
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
FEN1 |
FEN1, RAD2: Flap endonuclease 1 |
32.960 |
Evidence |
O
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
CDK2 |
CDK2: Cell division protein kinase 2 |
32.910 |
Evidence |
O
|
CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
CDK2 |
CDK2: Cell division protein kinase 2 |
31.410 |
Evidence |
O
|
RB1 |
RB1: Retinoblastoma-associated protein |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
31.040 |
Evidence |
O
|
CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
CXCR3 |
CXCR3, GPR9: C-X-C chemokine receptor type 3 |
30.090 |
Evidence |
|
CDK2 |
CDK2: Cell division protein kinase 2 |
CKS1B |
CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 |
28.700 |
Evidence |
O
|
LTA |
LTA, TNFB, TNFSF1: Lymphotoxin-alpha precursor |
TNF |
TNF, TNFA, TNFSF2: Tumor necrosis factor precursor |
27.950 |
Evidence |
O
|
U2AF2 |
U2AF2, U2AF65: Splicing factor U2AF 65 kDa subunit |
U2AF1 |
U2AF1, U2AF35, U2AFBP: Splicing factor U2AF 35 kDa subunit |
27.870 |
Evidence |
O
|
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
26.470 |
Evidence |
O
|
JUNB |
JUNB: Transcription factor jun-B |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
25.3 |
Evidence |
O
|
BCL2L1 |
BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X |
BAK1 |
IPI00003352 |
24.100 |
Evidence |
|
INHBA |
INHBA: Inhibin beta A chain precursor |
ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
23.250 |
Evidence |
|
TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
22.890 |
Evidence |
|
TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
22.890 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
22.290 |
Evidence |
O
|